Post-surgical changes in brain metabolism detected by magnetic resonance spectroscopy in normal pressure hydrocephalus: Results of a pilot study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 7, 2007, Pages 760-763

  Matarín, María Del Mar ^a   Pueyo, Roser ^a   Poca, María Antonia ^b   Falcón, Carles ^c   Mataró, María ^a   Bargalló, Núria ^d   Sahuquillo, Juan ^b   Junqué, Carme ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; CREATININE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITION; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; METABOLITE; NEUROPSYCHOLOGY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 34347255736     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.088450     Document Type: Article

References (26)

1. Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with "normal" cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 1965;273:117-26.
2. Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery 2001;49:1166-84.
3. Mataro M, Poca MA, Salgado-Pineda P, et al. Postsurgical cerebral perfusion changes in idiopathic normal pressure hydrocephalus: a statistical parametric mapping study of SPECT images. J Nucl Med 2003;44:1884-9.
4. Mataro M, Poca MA, del Mar MM, et al. CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2003;74:1272-7.
5. Poca MA, Mataro M, Sahuquillo J, et al. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2001;70:298-304.
6. Bluml S, McComb JG, Ross BD. Differentiation between cortical atrophy and hydrocephalus using 1H MRS. Magn Reson Med 1997;37:395-403.
7. Braun KP, Gooskens RH, Vandertop WP, et al. 1H magnetic resonance spectroscopy in human hydrocephalus. J Magn Reson Imaging 2003;17:291-9.
8. Braus DF, Ende G, Weber-Fahr W, et al. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol 2002;12:145-52.
9. Kalra S, Cashman NR, Genge A, et al. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757-61.
10. Narayanan S, De Stefano N, Francis GS, et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol 2001;248:979-86.
11. Braun KP, Vandertop WP, Gooskens RH, et al. NMR spectroscopic evaluation of cerebral metabolism in hydrocephalus: a review. Neurol Res 2000;22:51-64.
12. Kizu O, Yamada K, Nishimura T. Proton chemical shift imaging in normal pressure hydrocephalus. AJNR Am J Neuroradiol 2001;22:1659- 64.
13. Roelants-van Rijn AM, Groenendaal F, Stoutenbeek P, et al. Lactate in the foetal brain: detection and implications. Acta Paediatr 2004;93:937-40.
14. Ross B, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992;14:128-40.
15. Shiino A, Matsuda M, Morikawa S, et al. Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993;39:143-7.
16. Poca MA, Mataro M, Matarin M, et al. Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J Neurosurg 2004;100:855-66.
17. Lezak MD, Howieson DB, Loring DW. In:, Lezac MD, ed. Neuropsychological assessment. New York: Oxford University Press, Inc, 2004:1-995.
18. Sahuquillo J, Rubio E, Codina A, et al. Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called "normal pressure hydrocephalus" syndrome. Acta Neurochir (Wien) 1991;112:50-61.
19. Wikkelso C, Ekman R, Westergren I, et al. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur Neurol 1991;31:88-93.
20. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by (1)H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005;30:1949-62.
21. Stankoff B, Tourbah A, Suarez S, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 2001;56:112-15.
22. Rubin Y, Cecil K, Wehrli S, et al. High-resolution 1H NMR spectroscopy following experimental brain trauma. J Neurotrauma 1997;14:441-9.
23. Del Bigio MR, Wilson MJ, Enno T. Chronic hydrocephalus in rats and humans: white matter loss and behavior changes. Ann Neurol 2003;53:337-46.
24. Nakada J, Oka N, Nagahori T, et al. Changes in the cerebral vascular bed in experimental hydrocephalus: an angio-architectural and histological study. Acta Neurochir (Wien) 1992;114:43-50.
25. Moscovitch M, Nadel L. Consolidation and the hippocampal complex revisited: in defense of the multiple-trace model. Curr Opin Neurobiol 1998;8:297-300.
26. Valenzuela MJ, Sachdev PS, Wen W, et al. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage 2000;12:747- 56.